Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39022
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBONNECHERE, Bruno-
dc.contributor.authorAmin, Najaf-
dc.contributor.authorVAN DUIJN, Cornelia-
dc.date.accessioned2022-12-12T15:43:02Z-
dc.date.available2022-12-12T15:43:02Z-
dc.date.issued2022-
dc.date.submitted2022-12-05T11:13:15Z-
dc.identifier.citationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23 (22) (Art N° 13665)-
dc.identifier.urihttp://hdl.handle.net/1942/39022-
dc.description.abstractThere is a growing body of evidence highlighting there are significant changes in the gut microbiota composition and relative abundance in various neurological disorders. We performed a systematic review of the different microbiota altered in a wide range of neurological disorders (Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis, and stroke). Fifty-two studies were included representing 5496 patients. At the genus level, the most frequently involved microbiota are Akkermansia, Faecalibacterium, and Prevotella. The overlap between the pathologies was strongest for MS and PD, sharing eight genera (Akkermansia, Butyricicoccus, Bifidobacterium, Coprococcus, Dorea, Faecalibacterium, Parabacteroides, and Prevotella) and PD and stroke, sharing six genera (Enterococcus, Faecalibacterium, Lactobacillus, Parabacteroides, Prevotella, and Roseburia). The identification signatures overlapping for AD, PD, and MS raise the question of whether these reflect a common etiology or rather common consequence of these diseases. The interpretation is hampered by the low number and low power for AD, ALS, and stroke with ample opportunity for false positive and false negative findings.-
dc.language.isoen-
dc.publisher-
dc.rights2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).-
dc.subject.otherAlzheimer’s disease-
dc.subject.otherParkinson’s disease-
dc.subject.otheratrophic lateral sclerosis-
dc.subject.othergut microbiome-
dc.subject.othermultiple sclerosis-
dc.subject.otherstroke-
dc.subject.otherHumans-
dc.subject.otherAkkermansia-
dc.subject.otherPrevotella-
dc.subject.otherClostridiaceae-
dc.subject.otherClostridiales-
dc.subject.otherGastrointestinal Microbiome-
dc.subject.otherNervous System Diseases-
dc.subject.otherParkinson Disease-
dc.subject.otherMicrobiota-
dc.subject.otherMultiple Sclerosis-
dc.subject.otherStroke-
dc.titleWhat Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review-
dc.typeJournal Contribution-
dc.identifier.issue22-
dc.identifier.volume23-
local.bibliographicCitation.jcatA1-
local.publisher.placeST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND-
local.type.refereedRefereed-
local.type.specifiedReview-
local.bibliographicCitation.artnr13665-
dc.identifier.doi10.3390/ijms232213665-
dc.identifier.pmid36430144-
dc.identifier.isi000887481700001-
local.provider.typePubMed-
local.uhasselt.internationalyes-
item.validationecoom 2023-
item.contributorBONNECHERE, Bruno-
item.contributorAmin, Najaf-
item.contributorVAN DUIJN, Cornelia-
item.accessRightsOpen Access-
item.fullcitationBONNECHERE, Bruno; Amin, Najaf & VAN DUIJN, Cornelia (2022) What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review. In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23 (22) (Art N° 13665).-
item.fulltextWith Fulltext-
crisitem.journal.issn1661-6596-
crisitem.journal.eissn1422-0067-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
ijms-23-13665-v2.pdfPublished version5.26 MBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

10
checked on Apr 30, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.